Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2)

Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors

(2018) Michele Visentin et al.   DRUG METABOLISM AND DISPOSITION

Rat Organic Cation Transporter 1 Contains Three Binding Sites for Substrate 1-Methyl-4-phenylpyridinium per Monomer

(2018) Thorsten Keller et al.   MOLECULAR PHARMACOLOGY

Response to “Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1”

(2017) Gerard Minuesa et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover

(2017) Alyscia Cory Severance et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The role of interfacial lipids in stabilizing membrane protein oligomers

(2017) Kallol Gupta et al.   NATURE

Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol

(2017) David Dickens et al.   Scientific Reports

Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity

(2016) Zhibo Gai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transporter oligomerization: form and function

(2016) Y. Alguel et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions

(2016) Michele Visentin et al.   DRUG METABOLISM AND DISPOSITION

Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin

(2016) Yanqing Liu et al.   Science Translational Medicine

The SLC22 family with transporters of organic cations, anions and zwitterions

(2013) Hermann Koepsell   MOLECULAR ASPECTS OF MEDICINE

Substrate- and Cell Contact-Dependent Inhibitor Affinity of Human Organic Cation Transporter 2: Studies with Two Classical Organic Cation Substrates and the Novel Substrate Cd2+

(2013) Frank Thévenod et al.   MOLECULAR PHARMACEUTICS

How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains

(2013) Jacques Fantini et al.   Frontiers in Physiology

Differential changes in functional activity of organic cation transporters in rats with uranyl nitrate-induced acute renal failure

(2012) Han-Joo Maeng et al.   ARCHIVES OF PHARMACAL RESEARCH

A lipid-dependent link between activity and oligomerization state of the M. tuberculosis SMR protein TBsmr

(2012) Karsten Mörs et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Cholesterol-Independent Effects of Methyl-β-Cyclodextrin on Chemical Synapses

(2012) Kiel G. Ormerod et al.   PLoS One

Effect of Plasma Membrane Cholesterol Depletion on Glucose Transport Regulation in Leukemia Cells

(2012) Cristiana Caliceti et al.   PLoS One

The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization

(2011) Sabine Brast et al.   FASEB JOURNAL

Transport of Lamivudine [(-)- -L-2',3'-Dideoxy-3'-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3

(2009) G. Minuesa et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Testosterone‐Independent Down‐Regulation of Oct2 in the Kidney Medulla from a Uranyl Nitrate‐Induced Rat Model of Acute Renal Failure: Effects on Distribution of a Model Organic Cation, Tetraethylammonium

(2008) Won‐Sik Shim et al.   JOURNAL OF PHARMACEUTICAL SCIENCES